Biotech startup Loopworm has raised $3.3 Mn in its pre-Series A funding round co-led by WaterBridge Ventures and Enrission ...

Ensuring the safety and quality of pharmaceuticals, such as blood products, vaccines, recombinant proteins, and monoclonal antibodies, is essential. Endotoxins act as a hidden ‘time bomb’ in these ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

The growth of the recombinant proteins market is driven by advancements in biopharmaceutical research, increasing demand for personalized medicin ...

Loopworm, a biomanufacturing company developing insect-derived proteins, has raised $3.25 million in a pre-Series A funding ...

Loopworm, a Bengaluru-based biomanufacturing company developing insect-derived proteins, has raised $3.25 million Pre-Series ...

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

The global biologics market is estimated to be valued at USD 450.2 billion in 2025 and is projected to reach USD 1,077.2 billion by 2035, registering a CAGR of 9.1% over the forecast period. The ...

Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...

The new COVID-19 variant NB.1.8.1, known as Nimbus, is causing concern due to its subtle symptoms and high transmission rate.